Traditional drugs have become a subject of world importance, with both medicinal and economical implications. A regular and widespread use of herbs throughout the world has increased serious concerns over their quality, safety and efficacy. Thus, a proper scientific evidence or assessment has become the criteria for acceptance of traditional health claims. Plants of the genus Crataegus, Rosaceae, are widely distributed and have long been used in folk medicine for the treatment of various ailments such as heart (cardiovascular disorders), central nervous system, immune system, eyes, reproductive system, liver, kidney etc. It also exhibits wide range of cytotoxic, gastroprotective, anti-inflammatory, anti-HIV and antimicrobial activities. Phytochemicals like oligomeric procyanidins, flavonoids, triterpenes, polysaccharides, catecholamines have been identified in the genus and many of these have been evaluated for biological activities. This review presents comprehensive information on the chemistry and pharmacology of the genus together with the traditional uses of many of its plants. In addition, this review discusses the clinical trials and regulatory status of various Crataegus plants along with the scope for future research in this aspect.
Introduction
The genus name Crataegus, Rosaceae, is derived from a Greek word kratos meaning hardness of wood (Verma et al., 2007) . Crataegus comprises of a complex group of trees and shrubs, native to Northern temperate zones, mostly between latitudes 30° and 50° N. Crataegus belongs to the subfamily Maloideae in the Rosaceae, a natural group of complex genera with the ability to interbreed freely (hybridize). They all possess the basal chromosome number of 17. In general they do not form large trees or exist as canopy dominants in forests. Some species are decidedly shrubby, whereas others can grow to heights of 12 m, although most species can attain tree-sized proportions. Hawthorn refers to the plant Crataegus and is widely distributed throughout the Northern temperate region of the world with approximately 280 species (Robertson, 1974; Huang et al., 2004; Donmez, 2004) . Crataegus synonyms and common names in several European languages come from its physical characteristics of being a thorny bush, commonly used as hedging. The word 'haw' is an old English word for "hedge". The German hagedorn, meaning "hedgethorn", reveals that from a very early period, they were using Crataegus as hedging to divide their land into plots. The name 'may' is associated with the month in which the plant traditionally blossoms in England. Whitethorn Crataegus indicates the whiteness of its bark and the name 'Quickset' comes from its ability to establish itself rapidly. To appease their hunger before breakfast, farmers used to nibble on the flowers and leaves, hence the names Bread and Butter Tree or Bread and Cheese Tree.
General description
Leaves of the most species of Crataegus have two leafy bracts, their stalks meet the twig. Leaves are 15 mm-5 cm long, glabrous, broad-ovate or obovate and have toothed margins with three to seven lobes. The fl owers grow in clusters of 5-12 with colour ranges from white to pink, pink to red. They contain both male and female sexes and are mostly fertilized by insects, which are attracted by the perfume released by the fl owers. Red fruits are also known as Pixie Pears, Cuckoo's Beads and Chucky Cheese in some areas in England. These ovoid false fruits are known as Hawthorn berries which are greenish-red when they fi rst appear, gradually turning bright red and then a deep red. They have meaty white fl esh containing one or two stony fruits (WHO, 2003; Huang et al., 2004) .
Distribution
These small sized trees are grown as a hedge plant in Europe. Found mostly in temperate areas including countries like North Africa, Western Asia, India, China and North America. In the 1800s, British settlers introduced it into Tasmania and other parts of Australia as a hedge plant and it now runs wild in Victoria, Tasmania, the Adelaide Hills and the tablelands of New South Wales. Crataegus is an aggressive settler that i.e. tenacious and difficult to remove; it has been declared a noxious weed in many Australian states. In India, it is found in the temperate Himalayas, Kashmir and Himachal Pradesh, at an altitude of 1800-3000 m (Verma et al., 2007) .
Traditional use
Crataegus species (hawthorn) have been used traditionally since ancient times. Furthermore, it has been proposed that its antioxidant constituents account for its beneficial therapeutic effects. A decoction of leaves and unripe fruits from Crataegus aronia is used to treat cardiovascular diseases, cancer, diabetes and sexual weakness in Arabian traditional medicine system (Miller, 1998; Ju, 2005) . In Mexico, diabetes is treated with hawthorn extracts. Such treatment may be of considerable benefit especially during the early stages of the illness (Rigelsky & Sweet, 2002) . In folk medicine, several hawthorn species are mainly used for treating cardiovascular diseases including Crataegus pinntiflda (Chinese hawthorn), C. pubesens (Mexican hawthorn), C. cuneata (Japanese hawthorn), C. laevigata and C. monogyna (Europe), C. oxycantha and C. aronica (Middle East), C. phaenopyrum (American hawtrorn) and C. ambigua (Russian hawthorn) (Khalil et al., 2008; Ljubuncic et al., 2005) . Hawthorn (C. pinnatifida) is an edible fruit used in traditional Chinese medicine to lower plasma lipids (Lin et al., 2009) . Dried fruits of C. pinnatifida have been used traditionally as oriental medicine and local soft drink material in Taiwan (Kao et al., 2007) .
Chemistry
The leaves, flowers and berries of hawthorn contain a variety of bioflavonoid-like complexes that appear to be primarily responsible for the cardiac actions of the plant. Biflavonoids found in hawthorn plant include oligomeric procyanidins (OPC), vitexin, quercetin, and hyperoside. The action of these compounds on the cardiovascular system has led to the development of leaf and flower extracts, which are widely used in Europe. Other chemical constituents includes vitamin C, saponins, tannins, cardiotonic amines (phenylethylamine, tyramine, isobutylamine, O-methoxy phenylethylamine, choline and acetylcholine), purine derivatives (adenosine, adenine, guanine, caffeic acid, amygdalin), triterpene acids ursolic acid (Verma et al., 2007 Jayalakshmi et al., 2006; Garjani et al., 2000) .
Crataegus extracts also prevents elimination of plasma lipids such as total cholesterol, triacylglycerides and LDL and VLDL fractions (Ljubuncic et al, 2006; Andrade-Cetto & Heinrich, 2005) . Crataegus may be employed as antiinflammatory, gastro-protective, antimicrobial agent and used as hepatoprotective agent (Tadic et al., 2008; Kao et al 2005) . It is also mildly inhibits angiotensin converting enzyme (ACE) and reduce production of the potent blood vessel-constricting substance angiotensin II, hence act as hypotensive and diuretic (Schroder et al., 2003) . It mildly Hawthorn used as anti-atheromatous and coronarodilatating agent (Petkov, 1979) . The hydroalcoholic extract of Crataegus meyeri (1 mg/kg/ min) infused to rats, resulted in a significant decrease in the total number of ventricular ectopic beats. Chloroform extract of Crataegus meyeri (1 mg/kg/min) infused also reduced the total number of ventricular ectopic beats but this reduction was due to the decrease of single extra systoles. Hydroalcoholic and ethyl acetate infused extracts significantly reduced the time spent for ventricular fibrillation. During the extract infusion there were no significant changes in the heart rate and blood pressure but bolus injection of all the extracts significantly reduced the blood pressure. Thus, the extracts of Crataegus meyeri may possess active principles which have a hypotensive and antiarrhythmic potential on ischaemic myocardium (Garjani et al., 2000) . In another study Crataegus oxycantha extract was evaluated to prevent ischemia-reperfusion injury in an in vivo rat model of acute myocardial infarction. Crataegus extract (100 mg/kg body weight) showed a significant decrease in creatine kinase activity and infarct size. At the molecular level, Crataegus administration resulted in a significant attenuation of phosphatase and tensin homolog, deleted on chromosome, up regulation of phospho-Akt and c-Raf levels in the heart and this suggested that Crataegus extract attenuated apoptotic incidence in the experimental myocardial ischemia-reperfusion model by regulating Akt and hypoxia-inducible factor (HIF-1) signalling pathways (Garjani et al., 2000) .
Congestive heart failure
Crataegus is used widely in cardiology (Blesken, 1992) . The standardised extract of fresh berries of Crataegus oxyacantha L. and C. monogyna Jacq. (Crataegisan ® ) have shown potent effect in patients with cardiac failure NYHA class II. A total of 143 patients were treated with three times 30 drops of the extract or placebo orally administered for eight weeks. The results showed a significant improvement in their heart failure condition under long term therapy with the standardised extract of fresh Crataegus berries (Degenring et al., 2003) . In another study, the Crataegus extract WS 1442 inhibited balloon catheter-induced intimal hyperplasia in the rat carotid artery by directly influencing plateletderived growth factor receptor (PDGFR-beta). The results indicated that the polyphenols might be responsible lower blood pressure in some individuals with high blood pressure but should not be thought of as a substitute for cardiac medications for this condition. Crataegus showed high antioxidant and immunostimulating activity (Li et al., 2009) . Crataegus is also employed in CNS disorders like anxiety and mild depression (Hanus et al., 2004) .
Antihypertensive activity
It was observed that the hyperoside fraction and aqueous extract of Crataegus tanacetifolia prevented L-NAME-induced hypertension in rats and had beneficial effects on the cardiovascular system (Kocyildiz et al., 2006) . In another study, the camphor-crataegus berry combination (CCC) drops decreased the orthostatic fall in blood pressure (Belz et al., 2002) .
Anti-arrythmic activity
Crataegus oxyacantha extract was compared with other known cardioactive drug like ouabain, epinephrine, milrinone and propranolol for anti-arrthmic potential. Extract showed a unique activity profile as compared to conventional cardiac drugs. Its extract appeared to be capable of inducing rhythmicity in quiescent cardiomyocytes and showed antiarrhythmic activity. The commercial hawthorn preparations also exhibit similar chronotropic activities. Its extract also showed negative chronotropic effects and does not cause β-adrenergic receptor blockade (Long et al., 2006) .
Myocardial infarction
Crataegus extract (hawthorn) possess positive inotropic effect of amines such as phenethylamine, O-methoxyphenethylamine and tyramine. These amines were responsible for in vitro activity of Crataegus extracts on the guinea pig papillary muscle (Wagner & Grevel, 1982) and it also raised intracellular calcium thus prolongs the action potential, which supports for its inotropic activity (Kocyildiz et al., 2006) . In another study, alcoholic extract of Crataegus oxycantha (AEC) was found to maintain mitochondrial antioxidant status, decreased Kreb's cycle enzymes induced by isoproterenol in rat heart and prevented mitochondrial lipid peroxidative damage (Jayalakshmi et al., 2006) . to ameliorate post-angioplasty restenosis and prevent balloon catheter-induced intimal hyperplasia (Furst et al., 2010) .
Myocardial ischaemia

Antihyperlipdemic activity
Crataegus pinnatifida is an edible fruit used in traditional Chinese medicine to lower plasma lipids. A study was conducted on hawthorn fruits for investigation of its lipid-lowering property. Hawthorn powder extracts inhibited acylCoA: cholesterol acyltransferase (ACAT) activity in Caco-2 cells. The triterpenic acids like oleanolic acid and ursolic acid in the extracts were responsible for its cholesterol lowering effects and it was also found that plant sterol esters provide an additive effect in combination to triterpenic acids (Lin et al., 2009) . In another study aqueous extract of Crataegus aronica fruits exerted hypolipidaemic potential which was determined on rabbits fed with an atherogenic diet. Hawthorn fed rabbits showed inhibition of intestinal acylCoA: cholesterol acyltransferase without effecting the activities of hepatic 3-hydroxy-3-methyl glutaryl coenzyme A reductase (HMG-CoA-R) or cholesterol 7α-hydroxylase which explain its hypolipidaemic potential (Khalil et al., 2008) .
Antioxidant activity
Crataegus laevigata and C. monogyna (hawthorn) were subjected to drought and cold stress treatments, and such treatments caused enhanced the antioxidant capacity of the extracts (Kirakosyan et al., 2003) In another study, aqueous extract of leaves and unripe fruits of Crataegus aronia was investigated for its antioxidant potential which were found to be significant (Ljubuncic et al., 2005) . Other species of Crataegus exhibiting antioxidant activity includes C. pentaegyna (Ebrahimzadeh & Bahramian, 2009) , C. folium {Hawthorn} (Demiray et al., 2009 ).
Anticataract potential
Cataract is a multifactorial disease primarily associated with oxidative stress produced by free radicals and is the leading cause of blindness worldwide. Both in vitro and in vivo studies were undertaken to investigate the anticataract potential of Crataegus pinnatifida leaves extract. In vitro antioxidant assay of Crataegus pinnatifida leaves extract on NO (nitric oxide) production inhibition, aldose reductase inhibition, and O 2 -radical scavenging activities reveals its potential of antioxidant. The in vivo screening investigation of C. pinnatifida leaves extract eye drops in 0.1% hydroxypropyl methyl cellulose solution were prepared to evaluate the anticataract potential. Administration of leaves extract eye drops alternately three times a day in rat pupils with selenite-induced oxidative stress significantly increased serum superoxide dismutase (SOD) and catalase (CAT) activities and tended to reduce malondialdehyde (MDA) level compared with control group. The antioxidant enzymes SOD, CAT, and GSH (glutathione) activities in lens showed a significant increase, thus explains its antioxidant as well as anticataract potential (Wang et al., 2011) .
Anti-inflammatory, gastroprotective and antimicrobial activity
Crataegus monogyna, C. oxycantha and C. laevigata were shown anti-inflammatory, gastroprotective and antimicrobial activities. Oral administration of extract caused dose-dependent effect in a model of carrageenaninduced rat paw edema and showed anti-inflammatory activity. Extract also produced dose-dependent gastroprotective activity in ethanol-induced acute stress ulcer in rat model. The active components identified in the extract might be responsible for antimicrobial potential of the extract which was investigated against Gram-positive bacteria Micrococcus flavus, Bacillus subtilis, Lysteria monocytogenes and Candida albicans (Tadic et al., 2008) . Crataegus tanacetifolia (Lam.) extract had bactericidal effects (Benli et al., 2008) .
Antiviral activity
This activity was investigated on leaves and berries of three Crataegus species including C. aronia var. aronia, C. monogyna as well as C. pseudoheterophylla and was also evaluated for flavonoid amount and total proanthocyanidin content. Results revealed that the extracts containing these active constituents have been verified to be highly effective against Herpes simplex virus (Orhan et al., 2007) .
The flavonoids and trimeric procyanidin isolated from Crataegus sinaica demonstrated antiviral activity against HIV. Hyperoside, vitexin, 2"-O-rhamnosylvitexin, (4'"-O-acetyl)-2"-O-rhamnosylvitexin, epicatechin, (+)-taxifolin, 3-O-β-xylopyranosyl-(+)taxifolin may exert their antiviral effects by binding to the protein coat of the virus itself or by inhibiting reverse transcriptase in retroviruses like HIV (Shahat et al., 1998) .
Crataegus on reproductive system
Crataegus cuneata effect on reproductive system was evaluated using medicated serum prepared from its root part. This serum can improve in vitro sperm motility of asthenospermia patients. The sperm specimens of sixteen asthenospermia patients were coincubated with the medicated serum in vitro and sperm motility characteristics were evaluated by computerassisted semen analysis. When compared with the control group, the medicated serum significantly increased the sperm progressive motility in 5 and 15 min and the motility and progressive motility were both increased significantly in 60 and 120 min (Hu & Xiong, 2006) .
Radioprotective activity
The fruit of Crataegus microphylla extract when administered intraperitoneally at doses of 25, 50, 100 and 200 mg/kg, 1 h prior to gamma radiation, reduced the frequencies of micro nucleated polychromatic erythrocytes (MnPCE). All four doses of hawthorn extracts significantly reduced the frequencies of MnPCE and increased the PCE/ PCE+NC ratio (polychromatic erythrocytes/polychromatic erythrocytes+normochromatic erythrocytes) in mice bone marrow cells compared with the non drug treated irradiated control group. It appeared that hawthorn extract exhibits antioxidant activity and reduced the genotoxicity induced by gamma radiation in mouse bone marrow cells. Phytochemical study revealed that C. microphylla contains high amounts of phenolic compounds, chlorogenic acid, hyperoside and epicatechin which might be responsible for its radioprotective potential (Hosseinimehr et al., 2007) .
Immunostimulant activity
Water-soluble polysaccharide from Crataegus pinnatifida Bge. exhibits immunostimulant activity. Two sub-fractions of this polysaccharide fraction were evaluated on the basis of phagocytosis of macrophage assay, natural killer cells cytotoxicity and spleen lymphocyte proliferation assays. The results showed that these polysaccharides significantly induced phagocytic rates and phagocytic indexes by peritoneal macrophages and thus suggested that they should be explored as a novel potential immunostimulants from Crataegus (Li et al., 2009) .
Crataegus in anxiety and depression
A large randomized controlled trial (RCT) found that a combination of Crataegus oxyacantha (hawthorn), Eschscholzia californica (Californian poppy) and magnesium was more effective than placebo in reducing anxiety in 264 individuals with generalised anxiety disorder (Hanus et al., 2004) . Another study evaluated for the central effects of the phytotherapeutic product-CPV (dry extract of Crataegus oxyacantha, Passiflora incarnata and Valeriana officinalis) in animals models. Evaluation of anxiolytic effect of this extract on the elevated plusmaze (EPM) was carried out in order to investigate the psychopharmacological profile of CPV extract. CPV extract (430 and 860 mg/kg) presented an anxiolytic effect on rats (increased the number of entries into the open arms in the EPM) and, furthermore, a tendency of slight amnesic effect for the doses (430 and 860 mg/kg), but less intense when compared to diazepam (1.5 mg/kg), (Min et al., 2000; Tabach et al., 2009 ).
Diuretic/ACE inhibitor activity
A study had been done to check this activity experimentally which involves the use of a homeopathic Crataegus preparation Cralonin. In this study the efficacy of the homeopathic Crataegus preparation for non-inferiority to standard treatment for mild cardiac insufficiency was compared. Multicentre non-randomised cohort study was conducted in patients aged 50-75 years in New York Heart Association class II. Patients received Cralonin (ns110) or ACE inhibitor diuretics (ns102) for eight weeks. To adjust for confounding by baseline factors, populations were stratified according to propensity score. After adjusting, there were no statistically significant differences between treatment groups. The Crataegus-based preparation Cralonin is non-inferior to usual ACE inhibitor diuretics treatment for mild cardiac insufficiency on all parameters except BP reduction (Schroder et al., 2003) .
Hypoglycaemic activity
Diabetes mellitus is a syndrome which affects more and more people in all countries over the world. Crataegus containing herbal extracts were used widely to treat this condiction in Mexico. Such treatment may be of considerable benefit especially during the early stages of the illness. Crataegus mexicana Moc., C. pubescens, and C. presl root infusion containing active constituents like tannins and flavonoids may act as antidiabetic (AndradeCetto & Heinrich, 2005) . In another study the effects of a decoction prepared from the leaves and unripe fruits of Crataegus aronia, in streptozotocin-induced diabetic rats, were conducted and its effect on plasma and tissue indices of oxidative stress, as well as blood glucose levels was measured. This study concluded that decoction prepared from the leaves and unripe fruits of C. aronia normalizes plasma lipid peroxide levels and lowers blood glucose levels in diabetic (Ljubuncic et al., 2006) .
Hepatoprotective activity
Crataegus pinnatifida was investigated for hepatoprotective activity and the results suggested that this plant has anti-inflammatory potential which play a role in hepatoprotection (Kao et al., 2005) .
Cytotoxic activity
Cytotoxic ursane-type triterpenes were isolated from Crataegus pinnatifida which were identified as uvaol, ursolic acid and 3-oxo-ursolic acid. The cytotoxic activities of these compounds were tested in vitro against murine L1210 and human cancer cell lines (A549, SK-OV-3, SK-MEL-2, XF498, and HCT15). Uvaol and ursolic acid showed moderate cytotoxicities against L1210, whereas they showed weak activities against human cancer cell lines. However, 3-oxo-ursolic acid exhibited potent cytotoxic activities both in murine and in human cancer cell lines (Min et al., 2000) . Another study to clarify the active components in anti-transformation and anti-tumor promotion, involved the collection of the polyphenol fraction (CF-TP) of hot-water extracts from dried fruits of C. pinnatifida and different assays were conducted using this fraction such as anchorageindependent transformation assay. CF-TP significantly inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced cell transformation in JB6 P + cells. The results indicated that CF-TP significantly inhibited the generation of reactive oxygen species (ROS) and the phenomena of inflammation induced by TPA. It also suppressed the expression of COX-2 and iNOS, and the activation of ornithine decarboxylase (ODC). Furthermore, CF-TP inhibited benzo[α]pyrene (B[α]P)/TPA-induced skin tumor formation and decreased the incidence of tumor. The results revealed that CF-TP possesses potential as a cancer chemopreventive agent against tumor promotion (Kao et al., 2007) .
Miscellaneous
Crataegus species have number of various biological as well as pharmacological activities as shown in Table 1 . 
Dosage
Dosages of Crataegus extracts vary, depending upon concentration of extract. Therapeutic dose of an extract standardized to contain 1.8 percent vitexin-4-rhamnoside is 100-250 mg three times daily. A standardized extract containing 18% oligomeric procyanidins id dosed in the range of 250-500 mg daily (Monograph, 2010) .
Toxicology
Crataegus has been shown to have low toxicity with an LD50 of 25 mg/kg (Ammon & Handel, 1981a) . Commission E monograph states that mice and rats have been safely given a standardized extract at doses up to 3 g/kg body weight (Blumenthal et al., 1988) . Studies in rats using excessive dosing of hawthorn flower extract (600 mg/kg/day; flavonoids) over 30 days showed unremarkable adverse events. In humans the acute oral toxicity of hawthorn was 6 g/kg.
Contraindications
It is generally considered safe; however relative contraindications exist with cases of hypersensitivity or a history of an allergic reaction to Crataegus or any of its components. An absolute contraindication has been suggested in children under the age of 12 (Weikl et al., 1996; Ammon & Handel, 1981b) .
Side effects
Hawthorn was well tolerated in studies lasting up to sixteen weeks. Some side effects, while rare, may have been related to hawthorn extracts cited in the literature are: mild rash, headache, sweating, dizziness, sleepiness, agitation, gastrointestinal complaints (Houser, 2006) .
Drug interactions
The flavonoid components of hawthorn may be responsible for hawthorn's beneficial effects in the treatment of heart failure. However, these components may also affect P-glycoprotein function and cause interactions with drugs that are P-glycoprotein substrates, such as digoxin, which is also used to treat heart failure (Tankanow et al., 2003) .
Preparations
Tincture, decoction and powder.
Products
Tincture, capsule, tablet, bulk herb and syrup (Tankanow et al., 2003) .
Clinical trials of hawthorn (Crataegus)
Clinical trials are a means of developing new treatments and medications for diseases and conditions. Clinical trials are conducted to allow safety and efficacy data to be collected for health interventions (e.g., drugs, diagnostics, devices, therapy protocols). Clinical trial reviewed in this paper have been inconsistent in terms of criteria used (sample size, preparation and dosage, trial period, assessment method) but have been largely consistent with regards to positive outcome results. Adverse effect relating to the use of hawthorn preparations are infrequent and mild, even at higher dosage ranges but a retrospective study has suggested a negative results of the long term use of hawthorn in the prognosis of heart failure (Tassell et al., 2010; Zick et al., 2008) . Clinical studies on hawthorn (Crataegus) preparations have been shown in Table 3 .
Regulatory status for hawthorn in selected countries
Regulatory Affairs, also called Government Affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, and banking. Regulatory Affairs also has a very specific meaning within the healthcare industries (pharmaceuticals, medical devices, Biologics and functional foods) (Houser, 2006) Chart 3.
Worldwide used species of Crataegus as herbal drug or drug material
More than twenty species of hawthorn are used as herbal drugs or drug materials in the world. Some of them are officially listed in the pharmacopoeias of many countries such as China, Germany, France and England (Chang et al., 2002) Chart 4.
Conclusion
The medicinal properties of Crataegus species, Rosaceae, as discussed in this review paper highlighted significant pharmacological activities of this species. Pharmacological actions experimented on animals or in vitro models conclude its potential as cardioactive, hypotensive, hypolipidaemic, gastroprotective, hepatoprotective, antivirus, including anti-hiv, antioxidant, immunostimulant, antidiabetic, cytotoxic etc. Presence of bioflavanoids like oligomeric procyanidins, triterpenes, polysaccharides and other active compounds might be responsible for these pharmacological activities. It is believed that detailed information as presented in this review on its various biological properties, chemistry 
